The present invention generally relates to apparatus, systems and methods for processing and treating biological fluids, such as blood and blood components. More particularly, the present invention relates to disposable fluid processing sets used in the light-activated treatment of a biological fluid that contains a light activated photochemical agent, for the purpose of inactivating pathogens that may be present in such biological fluid. Even more particularly, the present invention relates to methods and apparatus for packaging and organizing the parts of the disposable fluid processing set in a way that makes the processing set easy to use by the end user.
Apparatus, methods and systems for treating biological fluids, such as blood and blood components, with light are well known. For example, U.S. Pat. No. 4,952,812, incorporated by reference herein, discloses an apparatus for treating unwanted white blood cells in platelet concentrate with ultraviolet radiation to limit the white cells' ability to trigger an immune reaction in a patient. To treat containers of platelet concentrate, the containers are placed on a slidable drawer that is introduced into a housing between facing arrays of lamps for irradiation from both sides of the container. During irradiation, the drawer (or a portion of the drawer) may be pivoted in a rocking motion to agitate the platelet concentrate.
U.S. Pat. No. 5,557,098, also incorporated by reference herein, discloses a system and apparatus for treating a biological fluid with light for the purpose of inactivating pathogens that may be present in the biological fluid. A slidable drawer is used to position the containers of biological fluid between facing arrays of light emitting diodes. Extended flaps on the containers, located outside the light field, are automatically punched to indicate different stages of the light treatment.
U.S. patent application Ser. No. 6,245,570, which is also incorporated by reference herein, discloses apparatus and methods for treating a container of a blood product between two facing arrays of light. The container includes a light sensitive tape which changes color when exposed to ultraviolet light, thereby indicating when the treatment process is complete.
Still other apparatus and systems for treating biological fluid are disclosed in U.S. Pat. No. 5,709,991, U.S. Pat. No. 6,190,609, and U.S. Pat. No. 6,433,343, all of which are incorporated by reference herein.
While the prior art apparatus, systems and methods have generally worked satisfactorily, efforts continue to develop new and improved apparatus, systems and methods that provide, for example, improved reliability, greater flexibility and efficiency, improved ease of use and serviceability, as well as enhanced tracking, record keeping and the like.
The following summary is intended as an overview of certain aspects of the present invention. It is not intended by this summary to limit or expand the scope of the claims, which define the scope of the present invention. The mention of certain features or elements in this summary does not mean that such elements or features are necessary to the use or practice of the invention in its broader or other aspects, or that such should be read into claims that do not expressly recite such feature or element. Conversely, the absence of any mention of certain elements or features is not intended to detract from the significance of such elements or feature in those claims in which they are expressly included.
In one aspect, the present invention is directed to a packaged fluid processing set that includes at least two flexible containers integrally connected by a flexible plastic tube. The packaged set includes at least one substantially rounded surface over which at least one of the containers is wrapped.
In another aspect, the present invention is directed to a disposable fluid processing set including a first portion and a second portion. The first portion includes at least one container. The second portion also includes at least one container. The two portions are integrally connected by a plastic tube. The set includes an organizer for receiving the second portion. The organizer is a folded sheet of a flexible material, wherein the facing sheet portions are secured to each other.
In another aspect, the present invention is directed to a disposable processing set that includes a first container including an inlet and an outlet and a treating agent within the container. The set includes a tube, with one end communicating with the inlet and defining an openable flow path. The set includes a second container and a tube, one end of which communicates with the first container and other end communicating with the second container and defining an openable flow path between the first and second containers.
In another aspect, the present invention is directed to a disposable processing set for treating a biological fluid that includes a first portion including a container for containing the biological fluid during treatment, a second portion including a container for receiving the biological fluid after treatment, and tubing connecting the containers and defining an openable flow path therebetween. The processing set includes a holder for temporarily holding the second portion separate from the first portion.
For purposes of illustration, the various aspects of the present invention will be described, in large part, in connection with their preferred embodiments. However, it should be recognized that the apparatus, systems and methods embodying the different aspects of the present invention are not limited to the specific details described herein.
An illumination device for treating a biological fluid is generally shown in
Light box 10 is particularly useful in the treatment of biological fluids. As used herein, biological fluid refers to any fluid that is found in or that may be introduced into the body including, but not limited to, blood and blood products. As used herein “blood product” refers to whole blood or a component of whole blood such as red blood cells, white blood cells, platelets, plasma or a combination of one or more of such components that have been separated from whole blood.
One specific, non-limiting use of light box 10 is in the treatment of a blood product that has been combined with a photochemical agent for activation when subjected to light. Such photochemical agents are used, for example, in the inactivation of viruses, bacteria, white blood cells and other contaminants (collectively referred to herein as “pathogens”). In pathogen inactivation applications, the activated agent inactivates pathogens that may be present in a blood product.
Typically, the biological fluid to be treated is introduced into a fluid treatment chamber within light box 10 in flexible, plastic, sterilizable, translucent, biologically compatible containers. In accordance with aspects of the present invention, the containers may be integrally connected to other containers and plastic tubing useful in the processing of the biological fluid both before and after the treatment provided by light box 10. Examples of the disposable processing set, its components and holders and/or organizers for such sets are shown in
a. Light Box
As shown in
For convenience and efficiency, it is preferred that light box 10 be fairly compact. In one, non-limiting example, light box 10 may be approximately 100 cm wide, 20-40 cm deep and between approximately 30-40 cm high. A compact instrument allows, for example, for placement of a greater number of instruments per treatment center and/or may allow two or more instruments to be stacked on top of each other (as shown in
Light box 10 may include a control module 26 and a fluid treatment module 28. As described in more detail below, control module 26 may include and/or house the command and control elements for the treatment of biological fluid. Fluid treatment module 28 houses the elements and components where fluid processing takes place.
Control module 26 and fluid treatment module 28 may be contained in the same housing but in a preferred embodiment, as shown in
Providing light box 10 in two readily separable modules 26 and 28 allows for easier access to the control and fluid treatment modules 26 and 28 and, generally, provides for easier serviceability of light box 10. For example, if off-site service is required for control module 26 only, that module can be removed without requiring removal and transport of the entire light box 10.
As shown in
The interior components of control module 26 are generally shown in
Control module 26 may be adapted for connection to external components such as a printer 500 (
Turning now to the fluid treatment module 28, as shown in
Returning to
As shown in
Turning more specifically to a description of fluid carrying drawer 50, as shown in
For ease of loading and unloading containers of biological fluid, fluid carrying drawer 50 preferably includes a pivot mount that permits the drawer to be tilted downwardly when fully withdrawn. The ability to tilt drawer 50 downwardly may be particularly useful for loading containers of fluid in the upper light boxes where two or more light boxes are stacked on top of each other, as shown in
To allow tilting of fluid carrying drawer, light box 10 may include spring loaded tilt knob 83 which, when pulled, releases fluid carrying drawer 50 and allows it to be tilted in the manner described above. More specifically, as shown in
As shown in
During treatment of the biological fluid, it may be desirable that the fluid within fluid carrying drawer 50 be continuously or periodically agitated to provide mixing of the biological fluid and ensure that substantially all of the biological fluid is sufficiently and uniformly exposed to light and/or any photochemical agent. Accordingly, fluid carrying drawer 50 may be attached to means for agitating the biological fluid.
As shown in
Light box 10 may include one or more light sources, preferably disposed above and below fluid treatment chamber 50. For ease of serviceability, such as lamp replacement, it is preferable that the light source(s) be readily accessible. As used herein, “readily accessible” means that access to the light source can be quickly and easily had without the use of, for example, a screwdriver or other tools. For example, in one embodiment, it may be desirable that the light source be either partially or completely removable from the housing 12 and/or fluid treatment module 28. The light source(s) may be accessible through any one of the front, side, top or bottom panels. In one embodiment, the light sources are housed in light drawers 60 and 70. As shown in
As shown in
Each of light chambers 101 and 103 of light drawer 60 or 70 is generally defined by four side walls 105a-d and a bottom wall 107. Walls 105a-d and 107 may be made of or coated with a reflective material to maximize the amount of light delivered to the biological fluid. In one specific embodiment, where the light source provides light in the ultraviolet A (UVA) range, walls 105a-d and 107 may be made of a highly reflective aluminum to provide substantial reflection of UVA light. Such a material is sold under the name 1500 G-2 and is available from ALANOD of Ennepetal, Germany.
The light sources suitable for use in the present invention may include any light source that is capable of providing light of a particular wavelength and intensity for treating a particular biological fluid. For example, light sources capable of providing white light, red light, infrared, ultraviolet A and/or B light may be used. Light drawers 60 and 70 may include a single lamp or an array of multiple lamps 100. In one embodiment, light source may include standard fluorescent lamps or bulbs capable of providing light of a wavelength in the UVA (ultraviolet A) range. Such lamps may be obtained from Sankyo Denki of Japan under the product code BL352. Light drawers 60 and 70 may optionally include fans 109 for cooling lamps 100 and, more specifically, ends of lamps 100 at or near the lamp filaments.
As shown in
As shown in
As set forth above, fluid treatment module 28 may, optionally, include marker assembly 74. Marker assembly 74 may include one or more markers 76a-76d for marking containers within fluid treatment chamber. One or more markers 76 may be provided to mark containers at different stages of the treatment. Markers 76a-d may be punches for punching holes into a portion of the container such as the container flap as described in U.S. Pat. No. 5,557,098, which is incorporated by reference. Alternatively, and more preferably, markers may be stampers for stamping designated portions of a container with ink. Such markers are commercially available from Trodat of Wels, Austria under the product name Printy 4911.
As shown in
As shown in
Fluid treatment module 28 includes blower 134 which provides air flow into fluid treatment chamber 40 and fluid containers and thus, provides for temperature control of fluid treatment chamber 40 (
Returning to the fluid treatment module 28 and more specifically fluid carrying drawer 50, as shown in
Where one or more containers are to be treated, tray 90 may be divided into a first portion 180 and a second portion 182 separated by dividing wall 184. As shown in
Where the biological container is part of an integrated fluid processing set, tray 90 may be compartmentalized to provide separate compartments for the container undergoing treatment on the one hand, and the remainder or a portion of the remainder of the disposable processing set, on the other hand. As shown for example, in
When the tray 90 with disposable processing set is introduced into fluid treatment chamber 50, container 206 within a first compartment 188 is positioned substantially within the field of light provided by the light source. The remainder of the disposable processing set and/or containers within a second compartment 190 is outside the field of light, preferably held in place by tray cover 380, described below. In the embodiment where marker assembly 74 is provided, containers within second compartment 190 are aligned substantially with marker assembly 74 as shown in
In an embodiment where the light box does not include a marker assembly, drawer 50 may include a cover 380 shown in
As shown in
Light box 10 may include sensors for detecting different conditions during the pretreatment and treatment process. The sensors relay signals to the microprocessor of the light box 10 which is housed within control module 26. As shown for example in
For example, light box 10 may include internal light intensity sensors 404 for measuring the intensity of light provided by the lamps 100 to fluid treatment chamber 50. In the event that the light intensity provided by lamps 100 is insufficient for the desired treatment, sensor 404 sends a signal through input/output board 170 (
In one embodiment, light intensity sensors 404 may be located within the light chambers 101 and 103 of light drawers 60 and 70 (
A fluid carrying drawer sensor 144 may be included for monitoring the position of fluid carrying drawer within fluid treatment chamber 40. Fluid carrying drawer positioning sensor 144 ensures that the drawer 50 is in a fully closed position and therefore, that containers of biological fluid are substantially within the field of light provided by lamps 100. If the drawer is not in a fully closed position, sensor 144 sends a signal to the microprocessor, alerting the operator and preventing treatment from proceeding.
Light box 10 may further include temperature sensors 145 for either directly or indirectly monitoring and measuring the temperature within fluid treatment chamber 40. Temperature sensor may be disposed within the fluid treatment chamber 40 or, as shown in
Additional sensors may be provided, including a sensor for monitoring the agitation provided by the agitation assembly. In one embodiment, sensor 430 may be attached to marker subassembly 74, as shown in
Light box 10 may also include a sensor 440 to detect whether the front door of the light box is closed during treatment. Door sensor may be a magnetic switch which detects contact between door 36 and magnetic plate 441 shown in
Light box 10 may also include sensors 450 for determining whether containers are present and/or in position for marking by markers 76. As shown in
In an embodiment where light box 10 does not include marker sub-assembly 74, the LEDs are located above compartments 190, aligned with apertures 384 in cover 380. Light from LEDS passes through apertures 384 in cover 380. Sensors 450 are aligned with the LEDs. As described above, if sensor receives the signal from the LED, this indicates that no container is present and the instrument will either alert the operator or terminate further processing.
In addition, a portable and attachable light intensity sensing, verification and calibration device or radiometer 460 may be provided to verify light intensity provided by light box 10 and for calibration of light box 10. Radiometer 460 may be adapted for placement within fluid treatment chamber 40 for measuring the energy dose delivered to the biological fluid. More specifically, radiometer 460 may be adapted for placement within the fluid container-carrying tray 90. In one embodiment, radiometer 460 may be adapted for placement within a compartment of tray 90 such as first compartment 188 of tray 90.
As shown in
It is known that a light source may not always uniformly emit light. For example, depending on the age of the lamp, the intensity of light emitted from one part of the lamp may not be the same as the intensity emitted from another part of the lamp. Accordingly, in a preferred embodiment, as shown in
An electrical cord (not shown) is attached to radiometer 460 for electrical connection to light box 10 and, for example, port 461 (
Sensors 469 may typically be photodiodes capable of detecting light of selected wavelengths. Sensors 469 may also include or be used with filters to filter out unwanted light as substantially described above.
When used in connection with light box 10, it is preferred that the dimensions of radiometer 460 be substantially equivalent to the dimensions of the fluid-filled containers used with light box 10. Accordingly, it is preferred that the light sensing area of radiometer 460 have a height, a width and a thickness substantially equal to such filled containers. A radiometer with dimensions substantially equal to the fluid-filled container provides a reliable approximation of the energy being delivered to the fluid and of the effectiveness of the treatment.
As set forth above, radiometer 460 may be used for light intensity verification by, for example, the operator and for calibration of light box 10 generally and more specifically, of internal sensors 404. In accordance with the method of using radiometer 460 for light intensity verification, the operator may place radiometer 460 in first compartment 188 of tray 90. Cord may be pressed into strain relief tabs 474 within light box 10 (
Thus, for example if the energy dose measured by radiometer 460 is substantially equal to the energy dose detected by sensors 404, but is outside the pre-set dose range, this may be an indication that the output of lamps 100 has diminished and that lamps 100 may have to be replaced. Alternatively, if the energy dose as measured by radiometer 460 is substantially equal to the expected pre-set dose of the instrument, but both are different from the energy dose as measured by sensors 404, this may be an indication that sensing capability of sensors 404 has diminished. Finally, if the dose as measured by sensors 404 is substantially equal to the expected pre-set dose, but different than the energy dose as measured by radiometer 460, this may indicate that the sensing capability of radiometer 460 has diminished. Radiometer may also be used to calibrate light box 10. Radiometer 460 itself may be calibrated against a standard (e.g. a standard from the National Institute for Standards and Technology or NIST).
Of course, it will be appreciated that radiometer 460 may have utility in other applications and is not limited to use in the apparatus or methods of the present invention. Indeed, radiometer 460 may be used whenever light is to be measured over an extended surface area.
In one embodiment, the components of the fluid treatment module 28 including the agitator assembly, the light sources, the blower, and the marker subassembly are powered by power supplies as shown in
Finally, light box 10 includes a programmable computer software-based control system to control the operation of light box. The control system is generally and diagrammatically depicted in
Modifications and alternatives to the features of light box 10, including the electrical interconnections, sensing systems, mechanical components, and the method of treating a biological fluid are also described in the U.S. Patent Application entitled “Apparatus, Systems and Methods for Processing and Treating a Biological Fluid With Light,” bearing Attorney Docket No. F8-5459 CIP, filed Oct. 11, 2002, previously incorporated by reference.
b. Disposable Processing Set
Disposable processing sets useful with light box 10 are generally shown in
One embodiment of a disposable fluid processing set 200 is shown in
Where the disposable processing set is used in or as part of a pathogen inactivation treatment, container 202 may include, for example, a treating agent such as a photochemical agent which is mixed with the biological fluid. Examples of such photochemical agents include psoralen compounds described in U.S. Pat. No. 5,709,991 and compounds from the family of phenothiazine dyes such as, but not limited to, methylene blue. Another example of a suitable agent is riboflavin. Container 202 may be made of any material suitable for holding such photochemical agents. One such material may be a blend of ethylene polypropylene, polyamide and a block copolymer of ethylene and butylene with terminal blocks of polystyrene. Containers made of such material are available from Baxter Healthcare Corporation under the name PL-2411. Container 202 includes a tubing segment 203 extending therefrom and having a sealed end 204. A second tubing 205 extending from container 202 is integrally connected to container 206. In another embodiment, the photochemical agent may be contained or predisposed within container 206, thereby eliminating the need for a separate container 202 for holding the photochemical agent. In still another embodiment, the photochemical agent may be combined with the biological fluid prior to joinder to the disposable processing set. For example, the photochemical agent may be included in a container 201 used to hold the biological fluid collected from a donor (
Container 206 is preferably a container suitable for holding the biological fluid during light treatment. Accordingly, it is desirable that container 206 be made of a clear, durable, thermoplastic material that is translucent to light of the selected wavelength and sterilizable by known forms of sterilization including steam sterilization, gamma and electron beam radiation. For example, where the blood product to be treated includes blood platelets or blood plasma and the treatment is to be with light in the UVA range, container is made of a material that is substantially translucent to UVA light and remains stable after sterilization. Such materials may include polyvinyl chloride, but more preferably, may be blends of thermoplastic polymers and copolymers, including general purpose polymers, elastomers and the like. One such material includes the block copolymer described above which includes a central block of ethylene and butylene and terminal blocks of polystyrene. Block copolymers of the type described above are available from the Shell Chemical Company under the name KRATON. The block copolymer may be blended with other polymers such as ultra low density polyethylene (ULDPE) and ethylene vinyl acetate (EVA). Containers made of the blended material are available from Baxter Healthcare Corporation of Deerfield, Illinois under the name PL-2410. Other thermoplastic materials may also be suitable for container 206, including materials including KRATON, EVA, and polypropylene. A container made from such material is also available from Baxter Healthcare Corporation under the name PL-732. Still other suitable materials for container 206 include fluoropolymers such as polytetrafluoroethylene (PTFE), PFA or copolymers including such fluoropolymers.
Container 206 further includes a slit 207 which, as described above, may be placed over retaining tab 186 in tray 90. Container 206 includes a tubing segment 208 which may be integrally connected to a container 210.
In the pathogen inactivation of biological fluid, container 210 may, for example, include an adsorbent material 211 for removing excess photochemical agent or the byproducts of the photoactivation process. The adsorbent material may be contained in a semi-permeable pouch, affixed to the container walls or portions thereof within the interior chamber of container 210 or, as shown in
Container 210 may also include a time-sensitive tape 209. Tape 209 changes color with time, thus informing the operator if the biological fluid has contacted the adsorbent material for a sufficient period of time.
Container 210 may be integrally connected by tubing segment 211 to another container 214 which may be suitable for storage of the biological fluid. As shown in
More preferably, the capturing device may be located in the flow path (“in-line”) of tubing 211, between container 214 and the outlet port of container 210, as shown in
Interior chamber 219 (shown in
The interior surface of at least one of walls 223 or 235 may be contoured. A contoured interior surface reduces the likelihood that filter element 221 will stick to the interior surface of the pouch wall. In one embodiment, the interior surface of one or both of walls 223 and 225 includes a plurality of ribs 223 that, as seen in
Where capturing device 211a is a pouch of the type shown in
Container 214 may include and/or be capable of receiving a label 216 which may carry bar codes 222 or other indicia which provide information about the biological fluid. For example, bar codes 222 may identify the donor, the product, the lot number of the biological fluid, expiration date and the like. Container 214 may include additional bar codes or indicia 224 which are used to provide information regarding the status or progress of the fluid treatment (described in more detail below). Container 214 may also include a slit 226 and/or apertures 228, 230 for placement over corresponding pegs (193) on tray 90. Materials such as those described above are suitable for use in container 214. Container 214 may also include one or more sampling pouches 214a and access ports 214b to allow for fluid access during later transfusion, as will be recoginzed by those of ordinary skill.
In an alternative embodiment, disposable processing set may include a single container for housing the adsorbent material of container 210 and for storing the biological fluid, thereby combining the functions of container 210 and 214 described above.
The disposable processing set 200 described herein may further include frangible members 230(a-c) disposed within tubing segments as shown in
Another embodiment of a fluid processing set is shown in
In contrast to the container 210 of the earlier described embodiment, container 246 is a flow through device which includes adsorbent material 212 but does not include a chamber for holding the biological fluid for any significant period of time. Such flow through devices are described in International Publication No. WO 96/40857 which is incorporated by reference herein. Disposable processing set 240 may optionally include an air reservoir 256 and air sink 258. Air reservoir 256 provides air to help expel biological fluid from container 244 and air sink 258 receives excess air expelled from storage container 248 after processing. Air reservoir 256 and air sink 258 may be made of any suitable biocompatible material, including the materials described above. Likewise, the containers of disposable processing set 240 may also be made from the materials generally described above. Preferably, container 256 is substantially impermeable to air.
As in the embodiment of
Disposable processing set 200 (or 240) is typically provided to the user in a sealed package in a manner that is easy for the user to unpack and use. For example, upon opening the package, it is preferred that the container to be used first in the fluid processing be located near the top of the package. For example, in the processing set 200 shown in
As shown in
In one specific, non-limiting embodiment, sheets 412 and 414 may be single sheets or a laminate of, for example, two sheets of polypropylene with a printed dye on one of the sheets. For example, one sheet of the laminate may be an oriented polypropylene while the other (e.g., inner) sheet of the laminate may be cast polypropylene. A poly AZO-type pigment or any other suitable pigment may be printed on one sheet (such as the oriented polypropylene sheet) of the laminate. Laminated sheets of the type described above are available from Hosokawa Yoko Co. of Tokyo, Japan.
The total thickness of sheets 412 or 414 (whether or not laminated) may be any thickness required to provide sufficient light blockage and protection against ozone. In one embodiment, the thickness may be between approximately 35-65 microns and more preferably approximately 50 microns.
Container 202 may be constructed by integrally sealing together the four outer (412, 414) and interior (416, 418) sheets at seal lines 419. Openings are provided for insertion of inlet and outlet tubes 420 and 422. After insertion of tubes 420 and 422, the open areas are sealed (by, for example, RF heat sealing) to provide a completely sealed 4-layered container. It will be understood that outlet tube 422 has been previously provided with a frangible connector member 230a. After introduction of the agent, an additional frangible connector member 230d is preferably bonded or otherwise attached to inlet tube 420.
For additional protection from light, a second light impermeable overwrap may be provided over container 202, as shown in
Sleeve 426 may be pre-sealed on at least two sides. The container 202 with integrally sealed overwrap is inserted through an open end of sleeve 426. The frangibles may then be connected to the outlet and, after introduction of the treating agent, the inlet. The remaining open ends of sleeve 426 may be at least partially sealed to retain container 202 within sleeve 426.
The material used for sleeve 426 may be the same material as the one described above in connection with sheets 412 and 414. Also, it should be understood that use of the double overwrap arrangement described above, although preferred, is not required. In other words, container 202 may include integrally sealed sheets 412 and 414, or be simply inserted in a sleeve, such as sleeve 426.
In a preferred embodiment, containers 210 and 214 may be contained within or held together by a holder or organizer. In one embodiment, holder may be any device such as a clamp that holds together containers 210 and 214. The holder may be integral with the disposable processing set or may be provided separately.
More preferably, holder 260, shown in
Alternative embodiments of holder 260 are shown in
In one embodiment, container 210 is placed in the front portion of holder 260, such that a label to be applied to the container 210 and other indicia on the container itself are exposed to the outside environment through the open portion of holder 260 as shown in
As shown in
Organizer 500 provides a support for the containers of disposable processing set 200 by folding sheet 502 along line 512, as shown in
Once organizer 500 has been configured into the U-shape, the containers 210 and 214 are wrapped around organizer 500, as shown in
Illumination container 206 may also be wrapped over the packaged containers for purposes of initial packaging and shipment, as shown in
As described above and shown in
As shown in
Another alternative embodiment of an organizer is shown in
After the components have been mounted on organizer 700, sheet 702 is folded. Sheet 702 may include spaced perforations 713 to allow sheet 702 to bend more easily and give the bent sheet the desired, U-shaped profile described above, thereby avoiding creasing of the containers. Once folded, tabs 714 are inserted into slots 716. Tab 719 is provided on the outer side of sheet 702 to receive the slit in the illumination container (e.g., 244), which for initial packaging and shipment is wrapped over folded organizer 702.
When the set is ready to be used in the photoactivation treatment, container 244 is removed from organizer 702 and biological fluid is introduced into container 244 (for example, through container 202), as described. The container with biological fluid therein is then placed inside compartment 188 of drawer tray 90. The package with the components of the processing set inside is then placed inside compartment 90 of light drawer 50. Organizer 700 includes an additional large tab 724. Tab 724 is scored or perforated along lines 726 to allow tab 724 to be folded. When the package is inside compartment 90, the tab 724 is folded back and holes 728 and 730 are placed over pegs 193 in light drawer 50, as shown in
Preferably, organizer 700 and more specifically sheet 702 is made of a sturdy, yet flexible material. A preferred material for organizer 700 is polyethylene, but any material that can be die cut and handled in the manner previously described, and is sterilizable by forms of sterilization used to sterilize the disposable processing set (e.g, e-beam or gamma radiation) may also be used. It is also preferred that organizer 700 be substantially opaque (i.e., not transparent) so as to attenuate the light from the bag indicating sensors in the light box, thus confirming the presence of the containers.
c. Methods of Processing and Treating Fluid
The method of processing fluid using disposable processing set 200 (or 240) and treating a biological fluid with light in, for example, light box 10 will now be described. Although the following description will be provided in the context of processing the biological fluid for subsequent inactivation of pathogens in the biological fluid, it should be understood that many of the steps described below may also be carried out in other fluid processing and treating methods that do not involve pathogen inactivation. The following description will be provided using the disposable processing set of
In accordance with the method of processing a biological fluid such as blood using the processing set 200, a container of collected blood or biological fluid is provided. Although the method of collection is beyond the scope of the present application, representative methods of collecting blood products include the automated and manual centrifugal processing, separation and collection of blood products, membrane separation of blood products and the like. One example of a centrifugal blood processing system is the AMICUS® Separator sold by Baxter Healthcare Corporation.
Regardless of the collection method, containers of the collected blood product will typically bear a label that includes information identifying the donor, the blood product and lot numbers. Most typically, such information is presented in the form of one or more bar codes on the label which can be scanned and read by bar code reader, such as bar code reader 41 of light box 10. Such labels may be removable and transferable to container 214 of the disposable processing set 200.
Typically, the collection container will include a tubing segment extending therefrom. Accordingly, tubing from the collection container 201 and tubing segment 203 from the disposable processing set 200 are brought together and joined in a sterile manner, as shown generally in
Once tubing segments have been joined, frangible member 230a is broken to provide an open flow path from the collection container 201 to the container 206 (
Before or after placement of the disposable processing set in tray 90, operator may scan the label and other container indicia with bar code reader 41. Bar codes 222 on the main container label 216 or the container itself provide the instrument with information regarding the biological fluid to be treated. Based on the data, the light treating instrument or operator prescribes the light dosage and then calculates the duration of the treatment.
Container 206 of disposable processing set 200 is typically placed in first compartment of tray 90. Slit 207 in container 206 is placed over retaining tab 186 in first compartment 188 and organizer 500 (or 700 ) with containers mounted thereon is placed within the second compartment 190 of drawer tray 90. Slits and/or apertures in container 216 are likewise placed over retaining tabs or pegs 193 in second compartment 190. Tubing connecting container 206 with container 210 (and/or 214) may be pressed into the slot in wall 192. It is preferable that the tubing be positioned parallel to the direction of the side-to-side oscillation provided by the agitator assembly described above. This further ensures that any fluid within tubing segment 208 is also mixed. Indicator 234b not only serves as a reference point for severance of the tubing but also serves as a reference point for container placement by ensuring that substantially the entire container and biological fluid therein is within the field of light. The indicator has a diameter greater than the width of the slot.
Once the containers are in their respective compartments of tray 90, fluid carrying drawer 50 is closed. As set forth above, plunger switch 36a (
Light box 10 includes a programmable computer software-based control system to control the operation of light box 10. The control system is generally and diagrammatically depicted in
For example as shown in
If the treatment function 306 is selected, the control system, through the programmed software will automatically determine if treatment is appropriate and more particularly, if the light box 10 is prepared for treatment as shown in
As shown in
After containers have been placed into tray 90, to commence treatment the system activates the light source(s) 100, shaker motor 92 and fans as shown in step 328 of
In one embodiment, container may be marked by markers 76 at the beginning of treatment and after treatment is completed. The marks made by marker 76 obliterate or otherwise masks the bar code, making it unreadable. Thus, a container with two masked bar codes 224 indicates that treatment has been successfully completed. On the other hand, if only one of the bar codes 224 has been masked, this serves as an indication that treatment was not successfully completed and the container may have to be discarded. Masking of bar codes 224 by markers 76 also ensures that a treated container will not be treated again.
During treatment, the system performs an energy calculation 332 which is computed by multiplying the light intensity sensor readings by preselected calibration factors, averaging the readings across the sensors in the same chamber and plane and adding the reading received for planes in the same chamber. The control system further verifies the treatment status 334. If treatment is completed, the system will automatically turn off lamps 100 as shown in 336.
The system may automatically update information on the lamp life as shown in 337 and update container records 338. Control system may continue to power shaker motor 92 until terminated. The results may be transmitted to a central computer 502 (
Treatment time and energy dosage will vary depending on the biological fluid to be treated. For example, the treatment time may be at least one minute but may also be less than one minute. Where light box 10 is used for the pathogen inactivation of biological fluid, the treatment may typically be anywhere between 1-30 minutes. For example, for the pathogen inactivation of blood platelets, treatment is typically between 1-10 minutes, but more typically approximately 3-4 minutes. For the pathogen inactivation of blood plasma, treatment may also preferably be approximately 3-4 minutes.
Energy per unit area, or energy flux, is the product of power per unit area or, in the case of radiant flux, at the target, and the time of exposure. Accordingly, the amount of energy per unit area delivered to the target (for example, in one embodiment, the biological fluid) will vary with the duration of exposure and the irradiance—the radiant power per unit area incident on the target. In one embodiment the total radiant energy flux delivered may be between approximately 1-100 J/cm2 measured across a wavelength range of between approximately 300-700 nm. However, any useful wavelength that activates photochemical agents may be used. In general, light box 10 can be retrofitted for various illumination frequencies to illuminate treatment targets in treatment chamber 40, including those light frequencies outside of the range of 300-700 nm. In another embodiment, where the light source provides light generally in the ultraviolet range, the total radiant energy flux delivered to the biological fluid may preferably be between 1-20 Joules/cm2 measured across a wavelength range of between approximately 320-400 nm. In one specific embodiment, the total radiant energy flux delivered to blood platelets or blood plasma may be between approximately 1-5 J/cm2 and more typically approximately 3-4 J/cm2 measured across a wavelength range of between approximately 320-400 nm. Preferably, the energy should not be outside the predetermined range in that excess heat generated within fluid treatment chamber 40 is to be avoided. For light treatment of blood platelets and blood plasma, for example, temperature within chamber 40 should typically not exceed 37° C. If an external temperature sensor of the type described above is used, the ambient temperature should be between 18°-30° C.
During treatment, tray 90 is preferably agitated at a preset frequency. Of course, the frequency should not be so great so as to harm the biological fluid or components thereof. Typically, the tray 90 may be agitated between approximately 400-100 cycles/min and for blood platelets, more preferably, between approximately 40-80 cycles/per minute. A cycle is defined as one complete back and forth oscillation of drawer 80. Additionally, it may be desirable for agitation to continue for up to 30 minutes after blood platelets have been treated with the desired target light dose, i.e., after illumination in light box 10 is terminated.
Once treatment has been successfully completed, fluid from container 206 may be transferred to container 210 by breaking frangible number 230b and opening the flow path between the containers 206 and 210 (
Alternatively, in the disposable processing set 240 shown in
The residence time, if any, of the biological fluid in container 210 (or 246) will be anywhere between approximately 30 seconds and 7 days. In addition, during contact of the biological fluid with the adsorbent material of container 210, it may be desirable to shake or otherwise agitate container 210 to ensure maximum contact with the adsorbent material.
Regardless of which disposable set is used, after the required residence time, if any, the biological fluid may be transferred to container 214 (or 248 in
In addition to the treatment function generally described above, the control system may prompt the operator to perform other functions such as the maintenance function 336 which may include printing a maintenance log 338, resetting lamp hours 340 resetting bag marker count 342. The operator may also select a system settings function 343 which allows the operator to set dates, times, languages 344,346,348. Finally, the control system may allow the operator to perform certain container management functions such as transmitting or printing container records or overwriting container records 350, 352, 354 as generally depicted in
Alternatively, the diagnostics function shown in general in
It will be appreciated that various modifications of the embodiments and methods described herein are possible in accordance with the scope of the present invention which are set forth in the appended claims.
This is a continuation-in-part of U.S. patent application Ser. No. 09/325,599, filed Jun. 3, 1999, now U.S. Pat. No. 7,025,877.
Number | Name | Date | Kind |
---|---|---|---|
3211368 | Shanley | Oct 1965 | A |
3221741 | LeVeen | Dec 1965 | A |
3399040 | Ilg | Aug 1968 | A |
3692493 | Terasaki | Sep 1972 | A |
3707806 | Toews et al. | Jan 1973 | A |
3737013 | Powell | Jun 1973 | A |
3870042 | Viguier | Mar 1975 | A |
3966286 | Groseclose | Jun 1976 | A |
3986506 | Garber et al. | Oct 1976 | A |
4035304 | Watanabe | Jul 1977 | A |
4066556 | Vaillancourt | Jan 1978 | A |
4073723 | Swank et al. | Feb 1978 | A |
4092246 | Kummer | May 1978 | A |
4162676 | Talcott | Jul 1979 | A |
4223675 | Williams | Sep 1980 | A |
4235233 | Mouwen | Nov 1980 | A |
4294247 | Carter | Oct 1981 | A |
4396383 | Hart | Aug 1983 | A |
4437472 | Naftulin | Mar 1984 | A |
4458733 | Lyons | Jul 1984 | A |
4484920 | Kaufman et al. | Nov 1984 | A |
4507114 | Bohman et al. | Mar 1985 | A |
4568328 | King | Feb 1986 | A |
4573960 | Goss | Mar 1986 | A |
4573961 | King | Mar 1986 | A |
4573962 | Troutner | Mar 1986 | A |
4578056 | King et al. | Mar 1986 | A |
4596547 | Troutner | Jun 1986 | A |
4608255 | Kahn et al. | Aug 1986 | A |
4623328 | Hartranft | Nov 1986 | A |
4670013 | Barnes et al. | Jun 1987 | A |
4726949 | Miripol et al. | Feb 1988 | A |
4776455 | Anderson et al. | Oct 1988 | A |
4786286 | Cerny et al. | Nov 1988 | A |
4834743 | Valerio | May 1989 | A |
4866282 | Miripol et al. | Sep 1989 | A |
4880425 | Kuhlemann et al. | Nov 1989 | A |
4900321 | Kaufman et al. | Feb 1990 | A |
4921473 | Lee et al. | May 1990 | A |
4938758 | Al-Sioufi | Jul 1990 | A |
4952812 | Miripol et al. | Aug 1990 | A |
4976707 | Bodicky et al. | Dec 1990 | A |
4976851 | Tanokura et al. | Dec 1990 | A |
4997083 | Loretti et al. | Mar 1991 | A |
5024536 | Hill | Jun 1991 | A |
5030200 | Judy et al. | Jul 1991 | A |
5049146 | Bringham et al. | Sep 1991 | A |
5080747 | Veix | Jan 1992 | A |
5087636 | Jamieson et al. | Feb 1992 | A |
5089146 | Carmen et al. | Feb 1992 | A |
5098371 | Juji et al. | Mar 1992 | A |
5100401 | Patel | Mar 1992 | A |
5128048 | Stewart et al. | Jul 1992 | A |
5154716 | Bauman et al. | Oct 1992 | A |
5176634 | Smith et al. | Jan 1993 | A |
5180504 | Johnson et al. | Jan 1993 | A |
5184020 | Hearst et al. | Feb 1993 | A |
5217627 | Pall et al. | Jun 1993 | A |
5269946 | Goldhaber et al. | Dec 1993 | A |
5290221 | Wolf et al. | Mar 1994 | A |
5298165 | Oka et al. | Mar 1994 | A |
5300019 | Bischof et al. | Apr 1994 | A |
5330462 | Nakamura | Jul 1994 | A |
5354262 | Boehringer et al. | Oct 1994 | A |
5373966 | O'Reilly et al. | Dec 1994 | A |
5403304 | Ishida | Apr 1995 | A |
5405343 | Mohr | Apr 1995 | A |
5417681 | Miyake et al. | May 1995 | A |
5427695 | Brown | Jun 1995 | A |
5445629 | Debrauwere et al. | Aug 1995 | A |
5456845 | Nishimura et al. | Oct 1995 | A |
5459030 | Lin et al. | Oct 1995 | A |
5462526 | Barney et al. | Oct 1995 | A |
5468373 | Chou | Nov 1995 | A |
5472621 | Matkovich et al. | Dec 1995 | A |
5503721 | Hearst et al. | Apr 1996 | A |
5507525 | Leuenberger | Apr 1996 | A |
5514106 | D'Silva | May 1996 | A |
5523004 | Tanokura et al. | Jun 1996 | A |
5527704 | Wolf, Jr. et al. | Jun 1996 | A |
5536238 | Bischof | Jul 1996 | A |
5543062 | Nishimura | Aug 1996 | A |
5545516 | Wagner | Aug 1996 | A |
5557098 | D'Silva | Sep 1996 | A |
5560403 | Balteau et al. | Oct 1996 | A |
5562836 | Joie et al. | Oct 1996 | A |
5571666 | Floyd et al. | Nov 1996 | A |
5573527 | Macabasco et al. | Nov 1996 | A |
5593823 | Wollowitz et al. | Jan 1997 | A |
5601730 | Page et al. | Feb 1997 | A |
5606169 | Hiller et al. | Feb 1997 | A |
5627426 | Whitman et al. | May 1997 | A |
5637451 | Ben-Hur et al. | Jun 1997 | A |
5658722 | Margolis-Nunno et al. | Aug 1997 | A |
5660731 | Piechocki et al. | Aug 1997 | A |
5683661 | Hearst et al. | Nov 1997 | A |
5691132 | Wollowitz et al. | Nov 1997 | A |
5695489 | Japuntich | Dec 1997 | A |
5709991 | Lin et al. | Jan 1998 | A |
5724988 | Dennehey et al. | Mar 1998 | A |
RE35804 | Stewart | May 1998 | E |
5772644 | Bark et al. | Jun 1998 | A |
5772880 | Lynn et al. | Jun 1998 | A |
5785700 | Olson | Jul 1998 | A |
5789150 | Margolis-Nunno et al. | Aug 1998 | A |
5792133 | Rochat | Aug 1998 | A |
5824216 | Joie et al. | Oct 1998 | A |
5836934 | Beshel | Nov 1998 | A |
5843049 | Heilmann et al. | Dec 1998 | A |
5858015 | Fini | Jan 1999 | A |
5858641 | Shanbrom | Jan 1999 | A |
5910138 | Sperko et al. | Jun 1999 | A |
5922278 | Chapman et al. | Jul 1999 | A |
5928213 | Barney et al. | Jul 1999 | A |
5935092 | Sun et al. | Aug 1999 | A |
5944709 | Barney et al. | Aug 1999 | A |
5951509 | Morris | Sep 1999 | A |
5954527 | Jhuboo et al. | Sep 1999 | A |
6190609 | Chapman et al. | Feb 2001 | B1 |
6190855 | Herman et al. | Feb 2001 | B1 |
6228995 | Lee | May 2001 | B1 |
6245570 | Grimm et al. | Jun 2001 | B1 |
6319662 | Foley et al. | Nov 2001 | B1 |
6544727 | Hei | Apr 2003 | B1 |
6565802 | Hanley et al. | May 2003 | B1 |
20020120224 | Zia et al. | Aug 2002 | A1 |
20030035751 | Hanley et al. | Feb 2003 | A1 |
Number | Date | Country |
---|---|---|
B-6339190 | Nov 1993 | AU |
0 196 515 | Aug 1986 | EP |
0 491 757 | Aug 1990 | EP |
0 526 678 | Oct 1993 | EP |
00 93 9469 | Jul 2002 | EP |
WO 9219284 | Apr 1992 | WO |
WO 9211057 | Jul 1992 | WO |
WO 9640857 | Dec 1996 | WO |
WO 9828057 | Dec 1997 | WO |
WO 9830327 | Jul 1998 | WO |
PCTUS0330074 | Sep 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20030146162 A1 | Aug 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09325599 | Jun 1999 | US |
Child | 10269444 | US |